Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Biederman

Showing results (321-330 of 581) with videos related to

Pageof 59
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|September 19, 2012
Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4TGagan Joshi, Joseph Biederman, Janet Wozniak, et al.
Psychiatry Research|November 14, 2012
Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot studyGeorge Bush, Jennifer Holmes, Lisa M Shin, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2003
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorderJennifer W Witcher, Amanda Long, Brian Smith, et al.
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
Developmental Neuroscience|April 13, 2021
Repetitive Mild Traumatic Brain Injury in a Perinatal Nicotine Exposure Mouse Model of Attention Deficit Hyperactivity DisorderLin Zhang, Cathy W Levenson, Valentina Cea Salazar, et al.
The Journal of Nervous and Mental Disease|January 3, 2012
Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional studyJoseph Biederman, Ronna Fried, Carter R Petty, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Autism and Developmental Disorders|March 24, 2010
The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred populationGagan Joshi, Carter Petty, Janet Wozniak, et al.
Journal of Child and Adolescent Psychopharmacology|November 20, 2018
A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum DisorderTolga Atilla Ceranoglu, Janet Wozniak, Ronna Fried, et al.
Journal of Psychopharmacology (Oxford, England)|March 8, 2019
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept studyJoseph Biederman, Annika Lindsten, Lasse B Sluth, et al.
Pageof 59

Showing results (321-330 of 581) with videos related to

Sort By:
Pageof 59
European Archives of Psychiatry and Clinical Neuroscience|September 19, 2012
Magnetic resonance spectroscopy study of the glutamatergic system in adolescent males with high-functioning autistic disorder: a pilot study at 4TGagan Joshi, Joseph Biederman, Janet Wozniak, et al.
Psychiatry Research|November 14, 2012
Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot studyGeorge Bush, Jennifer Holmes, Lisa M Shin, et al.
Journal of Child and Adolescent Psychopharmacology|June 14, 2003
Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorderJennifer W Witcher, Amanda Long, Brian Smith, et al.
BMC Psychiatry|September 18, 2007
Comparative acute efficacy and tolerability of OROS and immediate release formulations of methylphenidate in the treatment of adults with attention-deficit/hyperactivity disorderJoseph Biederman, Eric O Mick, Craig Surman, et al.
Developmental Neuroscience|April 13, 2021
Repetitive Mild Traumatic Brain Injury in a Perinatal Nicotine Exposure Mouse Model of Attention Deficit Hyperactivity DisorderLin Zhang, Cathy W Levenson, Valentina Cea Salazar, et al.
The Journal of Nervous and Mental Disease|January 3, 2012
Examining the association between stimulant treatment and cognitive outcomes across the life cycle of adults with attention-deficit/hyperactivity disorder: a controlled cross-sectional studyJoseph Biederman, Ronna Fried, Carter R Petty, et al.
CNS Spectrums|April 28, 2006
An open-label trial of OROS methylphenidate in adults with late-onset ADHDJoseph Biederman, Eric Mick, Thomas Spencer, et al.
Journal of Autism and Developmental Disorders|March 24, 2010
The heavy burden of psychiatric comorbidity in youth with autism spectrum disorders: a large comparative study of a psychiatrically referred populationGagan Joshi, Carter Petty, Janet Wozniak, et al.
Journal of Child and Adolescent Psychopharmacology|November 20, 2018
A Retrospective Chart Review of Buspirone for the Treatment of Anxiety in Psychiatrically Referred Youth with High-Functioning Autism Spectrum DisorderTolga Atilla Ceranoglu, Janet Wozniak, Ronna Fried, et al.
Journal of Psychopharmacology (Oxford, England)|March 8, 2019
Vortioxetine for attention deficit hyperactivity disorder in adults: A randomized, double-blind, placebo-controlled, proof-of-concept studyJoseph Biederman, Annika Lindsten, Lasse B Sluth, et al.
Pageof 59